Literature DB >> 4336945

Unstable variant of NADH methemoglobin reductase in Puerto Ricans with hereditary methemoglobinemia.

J M Schwartz, P S Paress, J M Ross, F DiPillo, R Rizek.   

Abstract

The electrophoretic mobility of erythrocyte NADH methemoglobin reductase in five hereditary methemoglobinemia patients from three Puerto Rican kindreds was 118% of normal at pH 8.6. The methemoglobin ferrocyanide reductase activity of the enzyme in erythrocyte hemolysates was 3.2-6.4% of normal. Electrophoresis of hemolysates prepared from the blood of patients from two different families at six pH values between 4.6 and 9.3 did not differentiate between the variant enzymes. Examination of the deficient enzymes extracted from the erythrocytes of one patient from each kindred revealed altered affinity for NADH and dichloroindophenol dye and decreased thermal stability. The quantitative similarity of the abnormal findings, together with the Puerto Rican origin of the kindreds, suggested that the cyanotic patients possessed the same abnormal enzyme and were thus homozygous for the same rare mutant gene. Consanguinity of the kindreds could not be established. The rates of decline of the normal and variant NADH methemoglobin reductase enzymes in vivo were measured in erythrocyte fractions of increasing cell age. The rate of decline of the variant enzyme was increased 20-fold by comparison with the normal enzyme. The methemoglobin percentage in erythrocyte fractions of increasing cell age correlated inversely with the activity of the variant. The variant enzyme averaged 37% of normal mean activity in young cells and 1% in old cells. The normal enzyme, on the other hand, lost only one-sixth of its activity as the cells aged, and the methemoglobin content in old normal cells did not rise. These observations support the hypothesis that the deficient activity and the heterogeneous pattern of methemoglobin accumulation in vivo arise principally from the accelerated inactivation of variant NADH methemoglobin reductase during the life-span of the red blood cell.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4336945      PMCID: PMC292298          DOI: 10.1172/JCI106957

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Heterogeneity of the enzymatic defect in congenital methemoglobinemia.

Authors:  G E Bloom; H S Zarkowsky
Journal:  N Engl J Med       Date:  1969-10-23       Impact factor: 91.245

2.  Electrophoretic study of glutathione reductase in human erythrocytes and leucocytes.

Authors:  J C Kaplan; E Beutler
Journal:  Nature       Date:  1968-01-20       Impact factor: 49.962

3.  The diaphorase bands of human erythrocytes.

Authors:  E Hegesh; N Calmanovici; M Lupo; R Bochkowsky
Journal:  J Lab Clin Med       Date:  1971-05

4.  Molecular pathology of human haemoglobin.

Authors:  M F Perutz; H Lehmann
Journal:  Nature       Date:  1968-08-31       Impact factor: 49.962

5.  In vivo lability of glucose-6-phosphate dehydrogenase in GdA- and GdMediterranean deficiency.

Authors:  S Piomelli; L M Corash; D D Davenport; J Miraglia; E L Amorosi
Journal:  J Clin Invest       Date:  1968-04       Impact factor: 14.808

6.  New method for determining ferrihemoglobin reductase (NADH-methemoglobin reductase) in erythrocytes.

Authors:  E Hegesh; N Calmanovici; M Avron
Journal:  J Lab Clin Med       Date:  1968-08

7.  Hydrogen peroxide toxicity and detoxification in the erythrocytes of newborn infants.

Authors:  R T Gross; R Bracci; N Rudolph; E Schroeder; J A Kochen
Journal:  Blood       Date:  1967-04       Impact factor: 22.113

8.  Red-cell "pseudomosaicism" in congenital methemoglobinemia.

Authors:  A S Keitt; T W Smith; J H Jandl
Journal:  N Engl J Med       Date:  1966-08-25       Impact factor: 91.245

9.  Electrophoretic and functional variants of NADH-methemoglobin reductase in hereditary methemoglobinemia.

Authors:  H S Hsieh; E R Jaffé
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

10.  Estimation of the molecular weights of proteins by Sephadex gel-filtration.

Authors:  P Andrews
Journal:  Biochem J       Date:  1964-05       Impact factor: 3.766

View more
  4 in total

1.  A patient with both methemoglobinemia and G6PD deficiency: A therapeutic conundrum.

Authors:  N Scott Reading; José A Ruiz-Bonilla; Robert D Christensen; William Cáceres-Perkins; Josef T Prchal
Journal:  Am J Hematol       Date:  2017-03-24       Impact factor: 10.047

2.  Concentration of NADH-cytochrome b5 reductase in erythrocytes of normal and methemoglobinemic individuals measured with a quantitative radioimmunoblotting assay.

Authors:  N Borgese; G Pietrini; S Gaetani
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

3.  Defective molecular variants of glucose-6-phosphate dehydrogenase and methaemoglobin reductase.

Authors:  J C Kaplan
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

4.  Methemoglobinemia in a young man.

Authors:  Yasmin S Hamirani; Wayne Franklin; Ronald G Grifka; Raymond F Stainback
Journal:  Tex Heart Inst J       Date:  2008
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.